Form 4: Insmed Inc. Director Alfred Altomari Acquires Restricted Stock Units

Director Alfred Altomari acquired 13,162 Restricted Stock Units (RSUs) of Insmed Inc. on May 13, 2024.

Summary

• On May 13, 2024, Alfred Altomari, a director of Insmed Inc., acquired 13,162 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Insmed Inc. common stock.
• The RSUs vest after one year, contingent upon the director remaining on the Board and attending at least 75% of Board meetings.
• Following the transaction, Altomari directly owns 69,495 shares of Insmed Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction and disclosure by a company director. The acquisition of RSUs is generally a positive sign, but it's a routine event.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the RSUs is contingent upon continued service as a director and attendance at board meetings, aligning the director's interests with the company's long-term success.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders, such as directors and officers, in the company's securities.

Stakeholder Impact

• The acquisition of RSUs by a director can positively influence shareholder sentiment, as it aligns the director's interests with the company's performance.

Key Dates